Kiely Wealth Advisory Group, Inc. Biogen Inc. Transaction History
Kiely Wealth Advisory Group, Inc.
- $158 Billion
- Q3 2024
A detailed history of Kiely Wealth Advisory Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Kiely Wealth Advisory Group, Inc. holds 247 shares of BIIB stock, worth $37,050. This represents 0.03% of its overall portfolio holdings.
Number of Shares
247
Previous 247
-0.0%
Holding current value
$37,050
Previous $50 Million
16.89%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,037Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.5 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.45 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.18 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.1 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$789 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...